Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”) today announced that Oren Gilad, Ph.D., President and Chief Executive Officer, will present a corporate overview and host 1x1 meetings at the Oppenheimer 33rd Annual Healthcare Conference, being held online from March 14-16, 2023.
March 7, 2023
· 2 min read